Investors:
Reduce Risk and Increase returns
through direct access to
promising growth companies.
Learn More
Strategic Partners:
Achieve Your M&A And Licensing
Goals By Easily Connecting With
Compelling Growth Companies.
Learn More
Growth Companies:
Increase Access To Capital, Deal
Certainty And Likelihood of "Exit".
Learn More
- Investors, growth companies and strategic partners, together transforming global healthcare capital markets -
$350M+
Capital Raised
40
Companies Funded
27
Strategic Deals
$2.2B+
"Exit" Value

Trending Now

- View All Companies -

Sequella

Sequella is a small molecule anti-infectives company developing first in class antibiotics to treat...

ClarVista Medical

Medical device company developing innovative products to treat challenging ophthalmic...


	First Aid Shot Therapy

F.A.S.T. products are FDA-compliant, one-step liquid medicine shots for pain and upset stomach...

Syndicate Leads

Leaders, Entrepreneurs & Investors who have generated a minimum of $100 million in historical shareholder value, who are investing their own capital and committing their time in creating their “Next Great Thing”

George Pitarra

George Pitarra Syndicate

The George Pitarra Fund is addressing the $7 billion blood stream infection (BSI) market with life-saving technology.

Learn More

Accelitech

Accelitech Syndicate

The Accelitech Funds are focused in the healthcare services sector and specifically on disruptive Oncologic technology.

Learn More

Healthtech Capital

Healthtech Capital

Dedicated to funding new "HealthTech" start ups at the intersection of healthcare with the computer and mobility worlds.

Learn More

Leonhardt Ventures

Leonhardt Ventures

BioLeonhardt, a Leonhardt Ventures company based in Los Angeles, will unveil its implantable Stem Cell Pump at the...

Learn More

Successful Raises

During the past 12 months, Healthios clients have raised more than
$300 million in financing. Notable recent closings include:

Miacom Diagnostics develops molecular diagnostic kits. The company distributes rapid molecular diagnostic tests for...
$5,000,000
Offered
$5,000,000
Raised
Closed
Days Left
Funded: $5,000,000 of $5,000,000
100%
Clear Vascular is a medical pharmaceutical company that develops pharmaceutical products for the treatment of cardio...
$4,000,000
Offered
$4,000,000
Raised
Closed
Days Left
Funded: $4,000,000 of $4,000,000
100%
Wellfont is an institutional pharmacy that believes healthcare can be offered with higher quality and at lower cost...
$22,500,000
Offered
$22,500,000
Raised
Closed
Days Left
Funded: $22,500,000 of $22,500,000
100%
Dicerna is a biopharmaceutical company focused on the discovery and development of company focused on the discovery...
$60,000,000
Offered
$60,000,000
Raised
Closed
Days Left
Funded: $60,000,000 of $60,000,000
100%

Case Studies

Healthios has advised on more than 80 healthcare transactions in 15 countries, representing more than $2 billion in transaction value.

Has completed a $25,000,000 Series A Financing

Series A Investment in
"Series D" company

In The News